476 reports of this reaction
4.6% of all ISTRADEFYLLINE reports
#4 most reported adverse reaction
DYSKINESIA is the #4 most commonly reported adverse reaction for ISTRADEFYLLINE, manufactured by Kyowa Kirin, Inc.. There are 476 FDA adverse event reports linking ISTRADEFYLLINE to DYSKINESIA. This represents approximately 4.6% of all 10,328 adverse event reports for this drug.
Patients taking ISTRADEFYLLINE who experience dyskinesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSKINESIA is moderately reported among ISTRADEFYLLINE users, representing a notable but not dominant share of adverse events.
In addition to dyskinesia, the following adverse reactions have been reported for ISTRADEFYLLINE:
The following drugs have also been linked to dyskinesia in FDA adverse event reports:
DYSKINESIA has been reported as an adverse event in 476 FDA reports for ISTRADEFYLLINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSKINESIA accounts for approximately 4.6% of all adverse event reports for ISTRADEFYLLINE, making it a notable side effect.
If you experience dyskinesia while taking ISTRADEFYLLINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.